Literature DB >> 12860935

Pemetrexed and cisplatin for malignant pleural mesothelioma: a new standard of care?

Valerie W Rusch.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12860935     DOI: 10.1200/JCO.2003.02.043

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  6 in total

1.  Early mesothelioma revisited.

Authors:  Seiki Hasegawa
Journal:  Int J Clin Oncol       Date:  2012-01-11       Impact factor: 3.402

2.  Virotherapy-recruited PMN-MDSC infiltration of mesothelioma blocks antitumor CTL by IL-10-mediated dendritic cell suppression.

Authors:  Zhiwu Tan; Li Liu; Mei Sum Chiu; Ka-Wai Cheung; Chi Wing Yan; Zhe Yu; Boon Kiat Lee; Wan Liu; Kwan Man; Zhiwei Chen
Journal:  Oncoimmunology       Date:  2018-10-16       Impact factor: 8.110

3.  Early-stage Clinical Characterization of Malignant Pleural Mesothelioma.

Authors:  Yoshiki Negi; Kozo Kuribayashi; Norihiko Funaguchi; Hiroshi Doi; Koji Mikami; Toshiyuki Minami; Teruhisa Takuwa; Takashi Yokoi; Seiki Hasegawa; Takashi Kijima
Journal:  In Vivo       Date:  2018 Sep-Oct       Impact factor: 2.155

4.  Chemotherapy management of malignant pleural mesothelioma: a phase II study comparing two popular chemotherapy regimens.

Authors:  E E Habib; E S Fahmy
Journal:  Clin Transl Oncol       Date:  2013-02-14       Impact factor: 3.405

Review 5.  Malignant mesothelioma: current status and perspective in Japan and the world.

Authors:  Seiki Hasegawa; Fumihiro Tanaka
Journal:  Gen Thorac Cardiovasc Surg       Date:  2008-07-08

6.  Imaging and therapy of malignant pleural mesothelioma using replication-competent herpes simplex viruses.

Authors:  Prasad S Adusumilli; Brendon M Stiles; Mei-Ki Chan; Michael Mullerad; David P Eisenberg; Leah Ben-Porat; Rumana Huq; Valerie W Rusch; Yuman Fong
Journal:  J Gene Med       Date:  2006-05       Impact factor: 4.565

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.